May 23, 2022 (Penny Stocks via COMTEX) -- 3 Penny Stocks to Add to Your Watchlist Right Now
If you're looking for the best penny stocks to buy, there are hundreds of options to choose from. And with a rather positive day of trading for penny stocks and blue chips , the market is ripe with opportunity. But, trading penny stocks is all about understanding exactly what is going on in the stock market.
And right now, the amount of momentum in the stock market means that this is more important than ever. As May comes to an end, the most crucial factors that are impacting the stock market are rising inflation rates, climbing interest, and geopolitical issues. All of this has created a highly volatile and reactive stock market that investors can take advantage of if they know what they're doing.
For those who don't know, penny stocks are shares that are worth less than $5 each. Because of this, they most of the time will be more volatile than their blue chip counterparts. But, this does not mean that there is no opportunity for profits. Rather, it provides more risk but also more potential reward. And with the right analysis and understanding, penny stocks can provide solid returns to investors.
However, it's important to remember that penny stocks are a highly speculative investment. This means that you should never invest more than you can afford to lose. With this in mind, let's take a look at three penny stocks to watch as May comes to an end.
3 Penny Stocks to Watch as May 2022 Ends
Regulus Therapeutics Inc. ( NASDAQ: RGLS )
Nerdy Inc. ( NYSE: NRDY )
Aethlon Medical Inc. ( NASDAQ: AEMD )
Regulus Therapeutics Inc. /zigman2/quotes/202916513/composite RGLS -6.21%
One of the larger gainers of the day is RGLS stock, which managed to push up by over 9% at EOD on May 23rd. And in the past five days, shares of RGLS stock have climbed by over 25%, which is no small feat. To understand why shares of RGLS stock are climbing, we have to take a look at its recent announcements and updates.
The most recent announcement from RGLS stock came on May 17th when it announced that its CEO and President, Jay Hagan, will be presenting at the H.C. Wainwright Global Investment Conference. If you're not familiar, Regulus Therapeutics is a biopharmaceutical company working on discovering and developing new medicines. These medicines are used in microRNAs and the company overall is working on pipelines for its oligonucleotide drug discovery program.
And only a few days before it, the company announced the acceptance of its IND from the FDA regarding its RGLS8429 for treating autosomal dominant polycystic kidney disease. All of this has made the company more popular in the past two weeks than it has been prior. Considering this, will it be on your list of penny stocks to watch or not?
Nerdy Inc. /zigman2/quotes/221611481/composite NRDY -2.39%
During trading and into after hours, shares of NRDY stock managed to climb by more than 17% and 5% respectively. To understand why shares are climbing, we have to take a look at what the company does and what it has been up to recently. Nerdy is a platform that allows for online learning utilizing technology. The company offers a large range of learning experiences with over 3,000 subjects and formats.
This includes self-study, large format group classes and much more. The most recent news from the company came on May 20th. On the 20th, the company announced a collaboration with the Smithsonian Institution. This collaboration will offer people around the world access to content from the Smithsonian. And, it will kick off with a group online class hosted on May 24th at 7 P.M.